id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3539-0030,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry;
Availability",Notice,Notice of Availability,2025-01-07T05:00:00Z,2025,1,,,2025-01-07T18:39:36Z,2024-31545,0,0,09000064868a35df
FDA-2015-D-3539-0031,FDA,FDA-2015-D-3539,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry",Other,Guidance,2025-01-07T05:00:00Z,2025,1,2025-01-07T05:00:00Z,,2025-10-17T09:00:21Z,,1,0,09000064868a4e3f